BioSpace News Archive

Monarch Waste Technologies, LLC, is a medical and hazardous waste disposal company founded in 2015 by David Cardenas and Kevin Yearout.

Lipocine Inc. announced that the first patient has been dosed in its LiFT Phase 2 clinical study, a paired-biopsy study in confirmed pre-cirrhotic non-alcoholic steatohepatitis subjects.

Evotec SE and Indivumed GmbH announced that the first milestone has been successfully achieved in their joint collaboration to identify new therapeutic targets for the treatment of colorectal cancer.

Lineage Cell Therapeutics, Inc. announced that updated results from a Phase I/IIa study of its lead product candidate, OpRegen®, a retinal pigment epithelium cell transplant therapy currently in development for the treatment of dry age-related macular degeneration, will be presented at the 2019 American Academy of Ophthalmology Annual Meeting, to be held at the Moscone Center in San Francisco, CA.

Sunovion’s support services program is recognized by J.D. Power for providing an outstanding customer service experience

Key requirements met to start Ytterbium-176 irradiation at Bruce Power’s facilities for the production of ITM´s no-carrier-added Lutetium-177 for cancer therapy

Oragenics, Inc. announces initial data from its ongoing Phase 2, placebo-controlled, clinical trial of AG013 in oral mucositis presented in a poster session at the European Society for Medical Oncology Congress 2019 in Barcelona, Spain.

Repro Med Systems, Inc. dba RMS Medical Products announced that R. John Fletcher has been appointed Chairman of the Board.

The St. John Fisher College Wegmans School of Pharmacy and 2U, Inc. announced a partnership to deliver a new clinically-oriented hybrid Pharm.D. pathway for aspiring pharmacy professionals in New York State and across the country.

Partnership to develop OCU400, Ocugen’s orphan drug designated gene therapy candidate in its modifier gene therapy platform